Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.
BMC Cancer.
2022,
22(1),
137,
ISSN: 1471-2407,
PMID: 35114947,